Financial Year |
March 31 2023 |
Monetary Funds |
3,324,694,367.69 |
Held-for-trading Financial Assets |
1,216,125,206.17 |
Notes Receivable |
3,979,742.90 |
Accounts Receivable |
1,784,092,865.74 |
Advances to Suppliers |
44,706,560.77 |
Other Receivables |
30,129,444.77 |
Amounts Due From Related Companies |
-- |
Interest Receivable |
-- |
Dividend Receivable |
-- |
Inventories |
2,007,947,313.83 |
Among: Consumptive Biological Assets |
-- |
Non-Current Assets Maturing Within One Year |
-- |
Other Current Assets |
512,129,610.79 |
Total Current Assets |
8,950,849,426.63 |
Available-for-Sale Financial Asset |
-- |
Held-to-maturity Investments |
-- |
Long-Term Account Receivable |
-- |
Long-term Equity Investment |
-- |
Investment Properties |
-- |
Fixed Assetes |
847,707,667.81 |
Under-construction Projects |
11,630,085.13 |
Construction Materials |
-- |
Disposal of Fixed Assets |
-- |
Capitalized Biological Assets |
-- |
Oil and Gas Assets |
-- |
Intangible Assets |
53,521,861.25 |
R&D expenses |
-- |
Goodwill |
-- |
Long-Term Deferred and Prepaid Expenses |
17,589,773.48 |
Deferred Income Tax Assets |
94,062,431.74 |
Other Non-Current Assets |
361,005,482.99 |
Sub-Total of Non-Current Assets |
1,385,517,302.40 |
Total Assets |
10,336,366,729.03 |
Short-Term Loans |
1,899,782,547.16 |
Trading Financial liabilities |
-- |
Notes Payable |
455,200,052.93 |
Accounts Payable |
1,195,430,113.21 |
Accounts Received In Advance |
-- |
Employee Compensation Payable |
89,251,280.31 |
Taxes Payable |
36,155,208.23 |
Interest Payable |
-- |
Dividend Payable |
-- |
Other payables |
13,101,473.62 |
Due to Related Companies |
-- |
Non-Current Liabilities Due Within One Year |
-- |
Other Current Liabilities |
96,272,050.34 |
Sub-Total of Current Liabilities |
4,102,343,343.67 |
Long-term Loans |
-- |
Bonds Payable |
-- |
Long-Term Accounts Payable |
-- |
Special Payable |
-- |
Estimatied Liabilities |
28,262,459.34 |
Deferred Income Tax Liabilities |
5,691,825.82 |
Other Non-Current Liabilities |
-- |
Sub-Total of Non-Current Liabilities |
37,463,762.76 |
Total Liabilities |
4,139,807,106.43 |
Paid-In Capital(Or Share Stock) |
523,233,750.00 |
Capital Surplus |
2,398,414,408.72 |
Surplus Reserve |
187,463,919.80 |
LESS:Treasury Stock |
-- |
Undistributed Profits |
3,077,057,122.62 |
Minority Stockholder's Interest |
10,794,634.55 |
Foreign Currency Capital |
-- |
Abnormal Management Project Income Adjusted |
-- |
Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
6,185,764,988.05 |
Owner's Equity(Stockholder's Equity) |
6,196,559,622.60 |
Total Liabilities and Owner's Equity(Stockholder's Equity) |
10,336,366,729.03 |